News & Insights Across Asia
AstraZeneca CEO Pascal Soriot expresses strong confidence in China’s economic growth and supply chain efficiency, highlighting its strategic importance to the company’s global operations.
Pascal Soriot, CEO of AstraZeneca, highlights China’s pivotal role in driving innovation in biopharmaceuticals at the Boao Forum 2024, noting the creation of well-paid jobs and a focus on quality productive forces.
AstraZeneca amplifies its presence in China with significant investments in Wuxi and Qingdao, focusing on innovation and R&D to advance global health and economic growth.